Intellia Therapeutics Aktie
9,98
EUR
+0,21
EUR
+2,17
%
11,88
USD
±0,00
USD
±0,00
%
Werbung
Intellia Therapeutics Aktie Analyse
| 15.05.18 | Intellia Therapeutics Buy | Chardan Capital Markets | |
| 28.03.17 | Intellia Therapeutics Buy | Chardan Capital Markets | |
| 31.05.16 | Intellia Therapeutics Outperform | Wedbush Morgan Securities Inc. |
Werbung
Werbung